Thyroid disorder Board decisions

The veteran's appeal for a compensable rating for hypothyroidism was dismissed because the veteran withdrew the claim.

The Board remanded the veteran's claims for service connection for obstructive sleep apnea and thyroid cancer. The veteran will get new medical opinions on these conditions.

The Veteran's pre-existing Hashimoto's disease was aggravated during active service, and the Board granted entitlement to service connection for this condition.

The veteran's claim for service connection for hypothyroidism was granted based on exposure to herbicide agents during active duty.

The Board denied initial compensable ratings for bilateral hearing loss, scars from thyroidectomy and knee surgery, low back strain, dyshydrosis, and hypothyroidism. It remanded decisions on a left eye chorioretinal scar and right knee benign tumor.

The Board denied the veteran's claims for an earlier effective date and a higher rating for hyperthyroidism, stating that the evidence did not support these requests.

The Board remanded the claim for service connection of thyroid cancer to schedule a VA examination considering exposure to PFAS in firefighting foam.

The Board denied service connection for all claimed conditions, including cervicalgia, headaches, hypothyroidism, PTSD, and seizures. The evidence did not show that these conditions began during active service or are related to an in-service injury or disease.

The Board remanded all issues for further development of evidence. The Veteran's claims for increased ratings and service connection are being sent back to the Regional Office for additional medical opinions.

The Veteran is granted special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities.

The veteran's claims for service connection for hypothyroidism, asthma, hypertension, diabetes, eczema, and secondary polycythemia vera were denied. The claim for parkinsonism was remanded.

The veteran's appeals for higher ratings and earlier effective dates for bladder cancer and hypothyroidism were dismissed because the veteran withdrew the appeals.

The Board granted service connection for the veteran's thyroid nodules, finding it at least as likely as not that the condition is due to in-service exposure to hazardous chemicals and/or toxins while stationed at Fort Richardson, Alaska.

The veteran's claims for increased ratings for several conditions were denied. However, service connection for hypertension under the PACT Act and for depressive disorder due to another medical condition was granted.

The Board remanded the case to obtain a medical opinion addressing whether the Veteran's thyroid condition is related to service, including exposure to contaminants at Camp Lejeune. The Board found that previous medical opinions did not adequately address key questions.

The Veteran's claims for hay fevers, disorder of the sacrum, neck disability, and bilateral hearing loss have been dismissed. The claim for service connection for primary hyperparathyroid condition has been granted on the merits with a reopening. New issues have been identified for remand related to eye condition, memory loss, osteoporosis, lactose intolerance, and chest pain.

The veteran's hypothyroidism rating was increased to 30% starting April 12, 2022. The VA denied a higher rating before this date.

The veteran's 50 percent rating for migraine headaches was restored. The claim for TDIU from August 30, 2021, was dismissed as moot due to a 100 percent disability rating for Hashimoto's. A TDIU was granted from February 1, 2021, to July 31, 2021.

The Veteran's service-connected disabilities render him unable to secure or follow a substantially gainful occupation, so he is granted total disability due to individual unemployability.

The Board denied service connection for hypothyroidism, stating that the evidence does not show a current diagnosis of this condition.